Axogen Inc vs FTAI Aviation Ltd — how do they compare? Axogen Inc trades at $39.4 (market cap $2.06B), while FTAI Aviation Ltd trades at $212.8 (market cap $21.17B). The key difference: FTAI Aviation Ltd is far larger — about 10.3× Axogen Inc's market cap, and FTAI Aviation Ltd pays a 0.73% dividend while Axogen Inc pays none. Which is the better fit depends on your goals.
| AXGN | FTAI | |
|---|---|---|
Market Cap | $2.06B | $21.17B |
Sector | Technology | Industrials |
52-Week High | $46.19 | $310.04 |
52-Week Low | $11.28 | $109.92 |
Enterprise Value | $1.98B | $24.21B |
Dividend Yield | — | 0.73% |
Signals from Pluang's Aura AI — not financial advice
AXGN trades at $39.49, down 2.69% today, with a bearish technical signal despite recent earnings volatility. The company reported mixed quarterly results with Q3 2025 beating estimates but Q1 2026 missing expectations. Strong analyst sentiment persists with 84% buy ratings and a $47.60 consensus price target, though negative profit margins and recent technical weakness create uncertainty.
The outlook remains cautiously optimistic given strong institutional support and reimbursement progress, but investors face risks from persistent losses and competitive pressures. The stock's current position near support at $39 suggests potential for recovery if upcoming Q2 earnings meet or exceed the $0.09 EPS estimate.
FTAI Aviation trades at $209.88, down 7.68% today, amid a bearish technical signal. The stock has missed earnings estimates for three consecutive quarters, though revenue and net income remain robust. Recent news highlights strategic collaborations and growth in data center power solutions. Analyst consensus is unanimously bullish with 18 buy ratings.
The outlook is supported by strong fundamentals and growth initiatives, but risks include earnings misses and high valuation multiples. The stock's near-term performance hinges on Q2 2026 results and execution of new business segments.
Trailing returns across standard periods
Latest headlines on both assets
Axogen is a leader in peripheral nerve regeneration and repair. It provides innovative surgical solutions and clinically proven products, like nerve grafts, to help restore function and quality of life for patients.
Read more on AXGN →FTAI Aviation owns and maintains a fleet of commercial aircraft and engines. It focuses on the specialized maintenance of the CFM56 engine, helping airlines reduce costs through efficient asset management.
Read more on FTAI →